Status: Not yet recruiting
A Study of SCTT11 in Healthy Participants and Participants with Thyroid Eye Disease.
Multicentre, Randomized, Double-blinded, Phase I/II Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SCTT11 in Healthy Participants and Participants with Thyroid Eye Disease
Participants needed: 100
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Sinocelltech Ltd.Updated: Jan 10, 2025
Eligibility criteria
Healthy male or female participants aged between18 and 45 inclusive [+1]
Male or female participants aged between 18 and 70 inclusive [+16]